BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37087333)

  • 1. Supplemental fibrinogen restores thrombus formation in cardiopulmonary bypass-induced platelet dysfunction ex vivo.
    Schoerghuber M; Bärnthaler T; Prüller F; Mantaj P; Cvirn G; Toller W; Klivinyi C; Mahla E; Heinemann A
    Br J Anaesth; 2023 Sep; 131(3):452-462. PubMed ID: 37087333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet function during cardiac surgery and cardiopulmonary bypass with low-dose aprotinin.
    Basora M; Gomar C; Escolar G; Pacheco M; Fita G; Rodriguez E; Ordinas A
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):382-7. PubMed ID: 10468248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet function defect of cardiopulmonary bypass.
    Kestin AS; Valeri CR; Khuri SF; Loscalzo J; Ellis PA; MacGregor H; Birjiniuk V; Ouimet H; Pasche B; Nelson MJ
    Blood; 1993 Jul; 82(1):107-17. PubMed ID: 7686785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Fibrinogen Concentrate on Neonatal Clot Structure When Administered Ex Vivo After Cardiopulmonary Bypass.
    Moiseiwitsch N; Nellenbach KA; Downey LA; Boorman D; Brown AC; Guzzetta NA
    Anesth Analg; 2023 Sep; 137(3):682-690. PubMed ID: 36727748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using reagent-supported thromboelastometry (ROTEM) to monitor haemostatic changes in congenital heart surgery employing deep hypothermic circulatory arrest.
    Straub A; Schiebold D; Wendel HP; Hamilton C; Wagner T; Schmid E; Dietz K; Ziemer G
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):641-7. PubMed ID: 18579398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes as a haemostatic adjuvant for post-cardiopulmonary bypass coagulopathy.
    Ishida O; Hagisawa K; Yamanaka N; Tsutsumi K; Suzuki H; Takikawa M; Takeoka S; Kinoshita M
    Sci Rep; 2020 Jul; 10(1):11308. PubMed ID: 32647296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic platelet anesthesia by glycoprotein IIb/IIIa complex antagonist and argatroban during in vitro extracorporeal circulation.
    Kanemitsu S; Nishikawa M; Onoda K; Shimono T; Shimpo H; Yazaki A; Tanaka K; Shiku H; Yada I
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):428-35. PubMed ID: 12928640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Prolonged Hypothermic Cardiopulmonary Bypass, Heparin, and Protamine on Platelet: A Small-Group Study.
    Epstein D; Vishnepolsky A; Bolotin G; Atweh N; Bonstein L; Lehavi A
    Thorac Cardiovasc Surg; 2021 Dec; 69(8):719-722. PubMed ID: 33465799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of normothermic versus hypothermic cardiopulmonary bypass on cytokine production and platelet function.
    Speziale G; Ferroni P; Ruvolo G; Fattouch K; Pulcinelli FM; Lenti L; Gazzaniga PP; Marino B
    J Cardiovasc Surg (Torino); 2000 Dec; 41(6):819-27. PubMed ID: 11232964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early platelet recovery following cardiac surgery with cardiopulmonary bypass.
    Van Poucke S; Stevens K; Wetzels R; Kicken C; Verhezen P; Theunissen M; Kuiper G; van Oerle R; Henskens Y; Lancé M
    Platelets; 2016 Dec; 27(8):751-757. PubMed ID: 27164510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care assessment of hypothermia and protamine-induced platelet dysfunction with multiple electrode aggregometry (Multiplate®) in patients undergoing cardiopulmonary bypass.
    Ortmann E; Klein AA; Sharples LD; Walsh R; Jenkins DP; Luddington RJ; Besser MW
    Anesth Analg; 2013 Mar; 116(3):533-40. PubMed ID: 23400974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet function during cardiopulmonary bypass using multiple electrode aggregometry: comparison of centrifugal and roller pumps.
    Kehara H; Takano T; Ohashi N; Terasaki T; Amano J
    Artif Organs; 2014 Nov; 38(11):924-30. PubMed ID: 24720284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation.
    Straub A; Wendel HP; Azevedo R; Ziemer G
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.
    Weber CF; Dietrich W; Spannagl M; Hofstetter C; Jámbor C
    Anesth Analg; 2010 Mar; 110(3):702-7. PubMed ID: 20042444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
    Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
    Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
    Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell responses.
    Rinder C; Fitch J
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S6-12. PubMed ID: 8938278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of ulinastatin on coagulation and platelet function in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass].
    Ji HW; Chen L
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):175-8. PubMed ID: 19537033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.